3-(3,4-bis(benzyloxy)phenyl)propan-1-ol | 524004-38-4

• 英文名称: 3-(3,4-bis(benzyloxy)phenyl)propan-1-ol
• 英文别名: 3-[3,4-Bis(phenylmethoxy)phenyl]propan-1-ol
• CAS: 524004-38-4
• 化学式: C₂₃H₂₄O₃
• 分子量: 348.442
• InChiKey: JKYXWACUGUGDOD-UHFFFAOYSA-N

物化性质

• 沸点：
  518.3±45.0 °C(Predicted)
• 密度：
  1.139±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  26
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(3,4-bis(benzyloxy)phenyl)propan-1-ol 在 30% Pd/C 、 氢气 、 一水合肼 、 三苯基膦 、 N,N'-羰基二咪唑 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 为溶剂， 20.0~60.0 ℃ 、101.33 kPa 条件下， 反应 55.0h， 生成 2-n-butyl-5-chloro-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylic acid[3-(3,4-dihydroxyphenyl)propyl]amide
  参考文献：
  名称：

  New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers

  摘要：

  We report new examples of a series of losartan-hydrocaffeic hybrids that bear novel ester, amide and amine linkers. These compounds were made by linking hydrocaffeic acid to the side chain of losartan at the C-5 position of the imidazole ring through different strategies. Experiments performed in cultured cells demonstrate that these new hybrids retain the ability to block the angiotensin II effect and have increased antioxidant ability. Most of them reduced arterial pressure in rats better or as much as losartan. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.01.043
• 作为产物：
  描述：

  3,4-二羟基苯基丙酸 在 甲醇 、 lithium aluminium tetrahydride 、 potassium carbonate 、 sodium hydroxide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 28.0h， 生成 3-(3,4-bis(benzyloxy)phenyl)propan-1-ol
  参考文献：
  名称：

  NANO-ADHESIVE AND SURFACE PRIMER COMPOUND AND USE THEREOF

  摘要：

  一种用于自组装到矿物和/或金属氧化物基底上的化合物，该化合物包括通过间隔基团连接到末端基团的邻苯二酚基团。该化合物包括以下结构的化学式（I）：

  公开号：

  US20200181455A1

文献信息

• [EN] PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSITIONS D'AMORCES PHOTOCLIVABLES ET PROCÉDÉ D'UTILISATION
  申请人：ACATECHOL INC

  公开号：WO2017132484A1

  公开（公告）日：2017-08-03

  In one embodiment, the present application discloses a photo-cleavable surface binding compound of the Formula I and Formula II: wherein the variables EG, EG1, SP1, SP2, SP3, Ar and BG are as defined herein. In another embodiment, the application discloses a method for forming a coating on a surface of a substrate using the surface binding compound.

  在一种实施例中，本申请公开了一种具有化学式I和化学式II的光解离表面结合化合物：其中变量EG、EG1、SP1、SP2、SP3、Ar和BG的定义如本文所述。在另一种实施例中，该申请公开了一种利用该表面结合化合物在基板表面形成涂层的方法。
• A Natural Product Inspired Tetrahydropyran Collection Yields Mitosis Modulators that Synergistically Target CSE1L and Tubulin
  作者：Tobias Voigt、Claas Gerding-Reimers、Tuyen Thi Ngoc Tran、Sabrina Bergmann、Hugo Lachance、Beate Schölermann、Andreas Brockmeyer、Petra Janning、Slava Ziegler、Herbert Waldmann

  DOI：10.1002/anie.201205728

  日期：2013.1.2

  the key step in the synthesis of tetrahydropyran derivatives. A phenotypic screen led to the identification of compounds that inhibit mitosis (as seen by the accumulation of round cells with condensed DNA and membrane blebs; see picture). These compounds were termed tubulexins as they target the CSE1L protein and the vinca alkaloid binding site of tubulin.

  聚合物结合的醛与均丙醇之间的Prins环化反应是合成四氢吡喃衍生物的关键步骤。通过对表型的筛选，可以鉴定出抑制有丝分裂的化合物（如带有浓缩DNA和膜泡的圆形细胞的积累所见；见图）。这些化合物被称为微管毒素，因为它们靶向CSE1L蛋白和微管蛋白的长春花生物碱结合位点。
• Photo-cleavable primer compositions and methods of use
  申请人：ACatechol, Inc.

  公开号：US10689407B2

  公开（公告）日：2020-06-23

  In one embodiment, the present application discloses a photo-cleavable surface binding compound of the Formula I and Formula II: wherein the variables EG, EG1, SP1, SP2, SP3, Ar and BG are as defined herein. In another embodiment, the application discloses a method for forming a coating on a surface of a substrate using the surface binding compound.

  在一个实施方案中，本申请公开了一种式 I 和式 II 的光可裂解表面结合化合物： 其中变量 EG、EG1、SP1、SP2、SP3、Ar 和 BG 如本文所定义。在另一个实施方案中，本申请公开了一种使用表面结合化合物在基底表面形成涂层的方法。
• Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias
  作者：Markus Stanek、Louis-Philippe Picard、Maximilian F. Schmidt、Jonas M. Kaindl、Harald Hübner、Michel Bouvier、Dorothée Weikert、Peter Gmeiner

  DOI：10.1021/acs.jmedchem.9b00349

  日期：2019.5.23

  Starting from the beta-adrenoceptor agonist isoprenaline and beta-blocker carvedilol, we designed and synthesized three different chemotypes of agonist/antagonist hybrids. Investigations of ligand-mediated receptor activation using bioluminescence resonance energy transfer biosensors revealed a predominant effect of the aromatic head group on the intrinsic activity of our ligands, as ligands with a carvedilol head group were devoid of agonistic activity. Ligands composed of a catechol head group and an antagonist-like oxypropylene spacer possess significant intrinsic activity for the activation of Gas, while they only show weak or even no beta-arrestin-2 recruitment at both beta(1)- and beta(2)-AR Molecular dynamics simulations suggest that the difference in G protein efficacy and beta-arrestin recruitment of the hybrid (S)-22, the full agonist epinephrine, and the beta(2)-selective, G protein-biased partial agonist salmeterol depends on specific hydrogen bonding between Ser(5.46) and Asn(6.55), and the aromatic head group of the ligands.
• PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE
  申请人：ACatechol, Inc.

  公开号：US20170217997A1

  公开（公告）日：2017-08-03

  In one embodiment, the present application discloses a photo-cleavable surface binding compound of the Formula I and Formula II: wherein the variables EG, EG1, SP1, SP2, SP3, Ar and BG are as defined herein. In another embodiment, the application discloses a method for forming a coating on a surface of a substrate using the surface binding compound.